EpiMedTech Global Launches epiGeneComplete: A Breakthrough Genetic and Epigenetic Test for Comprehensive Health Diagnostics

FOR IMMEDIATE RELEASE

Revolutionizing the early detection of health risks through cutting-edge DNA methylation and genetic analysis.

Singapore, 2024-10-30 – EpiMedTech Global is proud to announce the launch of epiGeneComplete, a groundbreaking clinical-grade test designed to provide comprehensive insights into key health factors, such as aging, stress, inflammation, addiction risk, and metabolism. Utilizing next-generation sequencing (NGS), this test combines DNA methylation and genetic (SNP) markers to offer unmatched accuracy in health diagnostics.

A New Era of Health Diagnostics

epiGeneComplete stands out as a revolutionary tool in personalized medicine, offering an unprecedented level of detail in assessing genetic and epigenetic markers. By analyzing a simple, non-invasive saliva sample, clinicians gain powerful insights into their patients’ health, improving early detection and enabling more personalized treatment plans.

“We are excited to introduce epiGeneComplete to the medical community,” said Moshe Szyf, Founder and CEO of EpiMedTech Global. “This test allows clinicians to assess a range of health risks at the epigenetic and genetic levels with superior accuracy. Designed as an open platform, new tests will be added as science advances and optimizations are made, ensuring that it remains at the forefront of medical diagnostics.”

High Sensitivity, Non-Invasive Testing

The test leverages advanced DNA methylation analysis and is performed in triplicate to ensure the highest degree of accuracy. It is a non-invasive, patient-friendly alternative to traditional diagnostic tools, making it ideal for routine screening.

epiGeneComplete is currently available exclusively through clinics and is performed in CAP-accredited laboratories, adhering to the highest clinical standards.

An Expanding Platform

epiGeneComplete is an evolving platform with new tests continuously integrated as scientific advancements occur. This provides clinicians with an ever-growing range of diagnostic capabilities, ensuring that patients receive the most up-to-date health insights.

Availability

Clinics interested in offering epiGeneComplete to their patients can contact EpiMedTech Global at info@epimedtech.com for more details. Patients are encouraged to consult their healthcare providers about the availability of this advanced diagnostic test.

About EpiMedTech Global

EpiMedTech Global is a leading innovator in personalized healthcare solutions, specializing in advanced DNA methylation and genetic testing. Our mission is to revolutionize health diagnostics, enabling earlier detection and more personalized care for improved patient outcomes.

For media inquiries, please contact:

Moshe Szyf
CEO
moshe.szyf@epimedtech.com
https://epimedtech.com/product/epigenecomplete/